infliximab (remicade) Report issue

Biologics mAb Orphan Drug FDA Approved FDA Accelerated Approval FDA
AACT ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH PubChem repoDB
Back

Drug Pricing Summary

VA Big4

$17.3455 - $456.7000

VA FSS

$25.2625 - $610.4100

VA NC

$121.4300

AUS PBS

$248.6465 - $257.0430

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
infliximab 100 mg (INJECTION) $17.3455 VA Big4
  • Renflexis (20)
    		•  Merck Sharp & Dohme Corporation
    infliximab 100 mg (INJECTION) $25.2625 VA FSS
  • Renflexis (20)
    		•  Merck Sharp & Dohme Corporation
    infliximab 100 mg (INJECTION) $121.4300 VA NC
  • Renflexis (1)
    		•  Merck Sharp & Dohme Corp.
    infliximab 100 mg (INJECTION) $248.6465 AUS PBS generic
  • Inflectra (1)
    		•  Pfizer Australia Pty Ltd
  • Renflexis (1)
    		•  Organon Pharma Pty Ltd
    infliximab 100 mg (INJECTION) $257.0430 AUS PBS generic
  • Remicade (1)
    		•  Janssen-Cilag Pty Ltd
    infliximab 100 mg / 10 mL (10 mL INJECTION) $165.5250 VA Big4
  • INFLECTRA (2)
    		•  Pfizer, Inc.
    infliximab 100 mg / 10 mL (10 mL INJECTION) $351.5600 VA FSS
  • INFLECTRA (2)
    		•  Pfizer, Inc.
    infliximab 100 mg / 10 mL (10 mL INJECTION) $364.2900 VA Big4
  • AVSOLA (1)
    		•  Amgen USA, Inc.
    infliximab 100 mg / 10 mL (10 mL INJECTION) $456.7000 VA Big4
  • REMICADE (1)
    		•  J & J Health Care Systems on behalf of Janssen Biotech Inc.
    infliximab 100 mg / 10 mL (10 mL INJECTION) $467.3400 VA FSS
  • AVSOLA (1)
    		•  Amgen USA, Inc.
    infliximab 100 mg / 10 mL (10 mL INJECTION) $610.4100 VA FSS
  • REMICADE (1)
    		•  J & J Health Care Systems on behalf of Janssen Biotech Inc.

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue